Treatment of respiratory disorders using ROR-gamma inhibitors

US9855229B2 · kind B2 · utility

Assignee

• Glenmark Pharmaceuticals S.A. · CH

Inventors

• Neelima Khairatkar-Joshi · Thane, IN
• Abhay Kulkarni · Navi Mumbai, IN
• Daisy M. Shah · Mumbai, IN
• Vikram M. Bhosale · Mumbai, IN
• Bhavik Jaysukhlal Lodhiya · Rajkot, IN
• Alamelu Mangai Thiraviam · Navi Mumbai, IN
• Megha Marathe · Thane, IN
• Avinash Annaso Hadambar · Satara, IN

Key dates

• Filing date: May 31, 2016
• Grant date: Jan 2, 2018
• Expiry date: May 31, 2036

Classification

• Technology area (CPC G): Physics
• CPC primary: G01N33/5088
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present patent application relates to treatment of a respiratory disorder using retinoid-related orphan receptor gamma t (ROR-gamma) modulators. Particularly, the present patent application relates to treatment of a respiratory disorder using a RORγ inhibitor, wherein the RORγ inhibitor is administered by an inhalation route to a subject in need thereof.